Managing your Inflammatory Back Pain Dr Amanda Isdale Rheumatologist York Teaching Hospital.

Slides:



Advertisements
Similar presentations
Ankylosing spondylitis
Advertisements

HOW TO MANAGE A FLARE Psoriatic Arthritis. What is psoriatic arthritis?
Reducing Need and Demand for Health Care Gero 302 Jan 2011.
Low back pain Implementing NICE guidance 2009 NICE clinical guideline 88.
Arthritis and Podiatric Medicine: Walking Hand-in-Hand Dr. Dennis R. Frisch 30 SE 7 th Street Boca Raton, FL
Rheumatoid Arthritis By, Marissa Miuccio.
RHEUMATOID ARTHRITIS AND REHABILITATION
All About Rheumatoid Arthritis
Ankylosing Spondylitis. ETIOLOGY/ PATHOPHYSIOLOGY Ankylosing spondylitis is a form of arthritis that is long-lasting (chronic) and most often affects.
SPONDYLOARTROPATHIES
Dr santosh kumar Assistant professor Medical unit 2.
SPONDYLOARTHROPATHIES Prof. Dr. Şansın Tüzün. Definition A family inflammatory arthritides characterized by involvement of both synovium and entheses.
Spondyloarthritis Khusrow Khidri Spondyloarthritis (or spondyloarthropathy) is the name for a family of inflammatory rheumatic diseases that cause.
UC. Ulcerative Colitis ( UC ) Ulcerative colitis is an inflammatory bowel disease (IBD) that causes chronic inflammation of the digestive tract It is.
THE ROLE OF THE HEART FAILURE SPECIALIST NURSE NHS Grampian Heart Failure Nurses November 2008.
EPIDEMIOLOGY Epidemiology of chronic kidney injury, including prevalence and prognosis in various community groups. Screening of populations for kidney.
Rheumatoid Arthritis Anila Malik GPVTS. Aims To cover the following: What is RA? Diagnostic criteria and clinical features Rheumatoid Factor Investigations.
BAD Biologic Interventions Register (BADBIR ) An update November 2010.
Community presentation: Low back pain. Overview Case history Case history Low back pain Low back pain Role of primary care Role of primary care Indicators.
3/4/03Steven Stoltz, M.D. Back Pain 2 nd most common cause for office visit 60-80% of population will have lower back pain at some time in their lives.
Exercise Management Cancer. Pathophysiology Cancer is not a single disease; it is a collection of hundreds of diseases that share the common feature of.
Improving Access to Musculoskeletal Services: A New Model of Care Ian Holding Senior Lecturer Musculoskeletal Medicine, Otago BSc, MBBCh, FRNZCGP, Dip.
September 15(C) Exact T & R Chronic Fatigue and physical activity.
This Back in Focus resource was developed and funded by AbbVie.. Date of preparation: June 2015; AXHUR150807p The Impact of Back Pain.
ANKYLOSING SONDYLITIS
AM Report 11/24/09 Amy Auerbach  Peak onset between 20 and 30 years  Form of spondyloarthritis (cause inflammation around site of ligament insertion.
Seronegative Spondyloarthropathies
Live Active / Vitality Introduction Lianne Thomas.
Dr Raj Sengupta Low Back pain. Definitive diagnosis difficult – not made in 85% Distinguish benign, self limiting disease (95%) from serious disease (5%)
Back Pain in General Practice Dr Chris Monella GPSI.
Rheumatology teaching session GP ST2 year 8/9/10.
Spondyloarthropathies. Introduction Spondyloarthropathy (Spondloarthritis) – Term for a group of chronic diseases – Affecting the joints of the spine.
Quality Education for a Healthier Scotland Pharmacy Pharmaceutical Care Planning Vocational Training Scheme: Level = Stage 2 Arlene Shaw Specialist Clinical.
Introduction to physiotherapy
Rheumatoid Arthritis Dr Chandini Rao Consultant Rheumatologist.
Issues in Australian Health Care. Vocabulary list Biomedical model of health, medicare, complementary health services, alternative health care services,
SARAH: Strengthening and Stretching for Rheumatoid Arthritis Affecting the Hand: A randomised controlled trial Adams J, Williams MA, Heine PJ, McConkey.
Disability Disability 1. Consequence of an impairment that may be:- Physical Cognitive Mental Sensory Emotional Developmental Combination.
Growing Health: The health and wellbeing benefits of community food growing How the health service can use food growing to deliver.
GRAPPA Guidelines for PsA: Considerations GRAPPA Guidelines Mission Statement: “To develop guidelines, based upon the best scientific evidence, for the.
Shoulder Pain: problems and solutions Ms. Ruth A. Delaney Consultant Orthopaedic Surgeon, Shoulder Specialist.
100 years of living science Chronic disease management in primary care: lessons to be learnt Dr Shamini Gnani November 2007, Mauritius.
Rheumatology What we do & How to help Ronan Mullan.
Copyright © 2013 by Mosby, an imprint of Elsevier, Inc. MOBILITY.
PUTTING PREVENTION FIRST Vascular Checks Dr Bill Kirkup Associate NHS Medical Director.
Musculoskeletal Research Collaboration Epidemiology Group, Institute of Applied Health Sciences An Update of AS Research Dr Gareth Jones Senior Lecturer.
Joint Injuries Arthritis By: Alessandro Iunni, Simon Da Silva, and Dylan Mugford.
What’s Hot in Spondyloarthritis
Heart Failure Services at STH: How it works and how End of Life issues are addressed Dr Soon H Song Consultant Diabetologist Acute Medicine Lead for STH.
Failure of 2 standard DMARDs including MTX for 6 months DAS28 > 5.1 on 2 occasions 1 month apart TOLERANT MTX Choose most appropriate agent and if no clear.
OSTEOPOROSIS Dr Annie Cooper Consultant Rheumatologist Royal Hampshire County Hospital Winchester.
Backgrond  Ankylosing spondylitis Condition in the spondyloarthritis (SpA) family of disease Chronic inflammatory arthritis characterized by sacroiliitis,
Powys teaching Health Board: Laying the Foundations for Good Health Our approach to delivering prudent healthcare By engaging with our population, and.
RNHRD AS rehabilitation course Dr Raj Sengupta. How the course started Allan St John Dixon Within 5 years of starting at the RNHRD.
Identifying Early Inflammatory Arthritis
Exploring the Natural History of Bone Marrow Oedema Lesions in
Inflammatory joint conditions
AS – the facts! Andrew Keat.
Approach to Diagnosis of Ankylosing Spondylitis Iraj Salehi-Abari MD
Prescribing.
EVALUATION AND TREATMENT OF ACUTE LOW BACK PAIN
Professor Colin P. Bradley University College Cork
Ankylosing Spondylitis ( A.S.)
Enteropathic Arthropathy
A Recommendation from Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from ACOP and APS By Rhys Dela Cruz, Angela Hickey,
What on earth is Spondyloarthritis
Axial Spondyloarthropathy
Dr Sarah Levy Consultant Rheumatologist CUH
Supporting people with axial spondyloarthritis
Psoriatic Spondyloarthropathies Dr Sarah Levy
Presentation transcript:

Managing your Inflammatory Back Pain Dr Amanda Isdale Rheumatologist York Teaching Hospital

Inflammatory Back Pain Presenting symptom of the Axial Spondyloarthropathy spectrum of diseases Chronic- more than 3/12 Gradual onset before age 45 years Relieved by exercise, no improvement with rest Relieved by NSAIDs

Estimated proportion of affected individuals* Time Spectrum of Axial Spondyloarthritis Axial SpA (ASAS criteria) Ankylosing Spondylitis (modified New York criteria) Patients with chronic back pain ≥3 months and aged <45 years Non-radiographic stage X-ray-negative MRI positive sacroiliitis MRI negative, HLA-B27-positive** Radiographic stage X-ray-positive sacroiliitis Radiographic stage X-ray-positive sacroiliitis and/or spinal changes*** * Heights reflect an estimate of the proportion of patients in each group ** Clinical arm if non-radiographic axial SpA *** Radiographic evidence if inflammatory spinal changes including i.e., syndesmophytes, fusion or posterior element involvement

Delays in diagnosis 15% of UK primary care population meet criteria for IBP Mean delay in diagnosis 8.57 years WHY? Patients not bothering to see GP- see other AHPs Failure to recognise symptoms Failure to image appropriately Belief that can be managed in primary care (35% of GPs)

But many common needs Getting the right diagnosis! Mechanical vs inflammatory vs other conditions; Non- radiographic axial SpA vs AS Seeing a specialist team Getting the right information Understanding the diagnosis Accepting the diagnosis Taking ownership

Management needs to tailored to an individual Dependent on: Stage of disease Severity of disease Activity of the disease General health of the patient Presence of other medical conditions Response and tolerance of pharmaceutical interventions

You have Axial SpA/AS Active vs passive acceptance Positive vs negative attitude Understanding your condition- reading the recommended PILs etc Seeking help when needed Accepting medication may be necessary Helping yourself

Lifestyle changes Stop smoking- known to result in poorer outcome and adverse effects on general health Lose weight if necessary aiming for healthy weight for height Avoid a sedentary lifestyle Listen to and follow the advice of your specialist team- particularly the physio Adjust work, hobbies and sport if required Invest in a good bed

The potential legacy of the disease without effective treatment

What happens to the spine in AS? The spine is like a suspension bridge It flexes and extends and is able to transmit and distribute force Remember Newton’s cradle with the 5 hanging balls? If it can’t move, it can’t transmit and distribute force

Getting the foundation right: Early disease Specialist Physiotherapy- exercise & stretching. Group sessions are better than individual: NASS classes, hydro sessions, Pilates classes, aqua- aerobics etc Adequate pain and anti-inflammatory relief to engage in the physio programme May require IM steroid to reduce inflammation or sometimes injection of steroid to the sacroiliac joints Managing fatigue

Established Spinal Disease: AS Physio exercises & stretching NSAIDs & analgesics Using IM steroid for flares Assessing for osteoporosis Identifying fracture vs flare Managing eg hip disease with replacement

Other non-spinal considerations Peripheral joints & entheses Eye disease: uveitis- can occur at any time, usually 1 eye at a time; generally better on anti-TNF Gut disease: NSAID related; Inflammatory bowel disease- may present insidiously Skin: psoriasis Cardiovascular: heart valve disease; arrhythmias etc

Management Spine: Failure of Standard Interventions If there is poor response to these interventions; assess for biologic agents Anti-TNF( Etanercept, Adalimumab, Golimumab, Certolizumab) Require measures of active disease (BASDAI & pain >4) on 2 occasions 3/12 apart + use of 2 full strength NSAIDs +other non AxSpA criteria for use

To ponder Anti-TNF:effective disease modifying but not curative therapies New biologics on stream targetting different pathways Biosimilars- cheaper (slightly), ?similar Remission? Early treatment better outcomes. When to reduce/stop? What can we afford in the future? Not everyone needs anti-TNF- getting the right balance but not missing the boat

Summary Early diagnosis is essential Self management & taking ownership of your condition are of paramount importance Exercise, stretching & lifestyle adjustments are still the foundation stones Biologic drug treatment has been a major advance but are not a cure & they can have limitations